Development of Novel Ligand-Drug Hybrid Nanocrystals to Target Breast Cancer

Pharmacology, Toxicology and Pharmaceutical Science

1. Breast Cancer 100%
2. Neoplasm 100%
3. Dosage Forms 100%
4. Receptor 100%
5. Drug Delivery System 100%
6. Side Effect 100%
7. Nanocrystal 100%
8. Paresthesia 50%
9. Cytotoxicity 50%
10. Hair Loss 50%
11. Malignant Neoplasm 50%
12. Paclitaxel 50%
13. Diarrhea 50%
14. Immunogenicity 50%
15. Chemotherapy Agent 50%
16. Chemotherapy Regimens 50%
17. Anticarcinogen 50%